Company Market Cap Key Therapeutic Areas of Focus
----------------------------------- ------------ --------------------------------------------------
Editas Medicine (NASDAQ:EDIT) $1.9 billion Leber congenital amaurosis 10, sickle cell disease
Intellia Therapeutics (NASDAQ:NTLA) $8.9 billion Transthyretin (ATTR) amyloidosis
Verve Therapeutics (NASDAQ:VERV) $1.9 billion Cardiovascular diseases
What company is the king of genome sequencing?
About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets.